SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (950)2/8/2002 6:31:57 PM
From: Jim H  Read Replies (1) of 2243
 
Rick:

I don't post often due to my extreme ignorance.
However, I came across one that seems to fit the
mold around here. The stock is BioReliance (BREL).
They have labs around the world where they do contract
research and manufacturing. Established company.
Profitable. Ascending top line. Reasonable PE. Also
a bio terrorism play.

I believe that BREL will stand to benefit from
increased activity in the biotech sector. Trickle
stock.

Good presentation at JPM H&Q available on web.

Jim H
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News